|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-10-27
|
|
pubmed:abstractText |
To the authors' knowledge, the prognostic factors in recurrent small cell lung cancer (SCLC) patients treated with second-line chemotherapy have not yet been clearly identified to date.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2518-23
|
|
pubmed:meshHeading |
pubmed-meshheading:18780323-Adult,
pubmed-meshheading:18780323-Aged,
pubmed-meshheading:18780323-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18780323-Drug Resistance, Neoplasm,
pubmed-meshheading:18780323-Female,
pubmed-meshheading:18780323-Humans,
pubmed-meshheading:18780323-Lung Neoplasms,
pubmed-meshheading:18780323-Male,
pubmed-meshheading:18780323-Middle Aged,
pubmed-meshheading:18780323-Neoplasm Recurrence, Local,
pubmed-meshheading:18780323-Neoplasm Staging,
pubmed-meshheading:18780323-Prognosis,
pubmed-meshheading:18780323-Remission Induction,
pubmed-meshheading:18780323-Retrospective Studies,
pubmed-meshheading:18780323-Sensitivity and Specificity,
pubmed-meshheading:18780323-Small Cell Lung Carcinoma,
pubmed-meshheading:18780323-Survival Rate,
pubmed-meshheading:18780323-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
|
|
pubmed:affiliation |
Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
